SleepX

SleepX is a biotechnology company focused on developing innovative cannabinoid-based therapies for the treatment of sleep disorders, specifically sleep apnea. Acquired by Enveric Biosciences in 2021, the company utilizes a proprietary platform to create formulations that target the underlying mechanisms of sleep-disordered breathing. Its lead research involves combining cannabinoids with other synergistic compounds to improve respiratory stability during sleep. The company's operations are integrated into Enveric's broader portfolio of psychedelic and cannabinoid-inspired treatments for mental health and supportive care. SleepX aims to provide a pharmacological alternative to mechanical treatments like CPAP machines, which often suffer from low patient compliance. The company's technology includes a unique delivery system designed to optimize the therapeutic effect of its cannabinoid formulations.